Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 14.56
+0.60 (4.30%)
Oct 31, 2025, 4:08 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 9.79 billion as of October 31, 2025. Its market cap has increased by 364.59% in one year.
Market Cap
9.79B
Enterprise Value
7.32B
Revenue
678.11M
Ranking
n/a
PE Ratio
59.67
Stock Price
14.56
Market Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has increased from 8.71B to 9.79B, an increase of 12.39%. That is a compound annual growth rate of 2.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 9.79B | 240.36% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | 8.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.66B |
| Hansoh Pharmaceutical Group Company | 215.76B |
| JD Health International | 194.33B |
| Innovent Biologics | 149.08B |
| WuXi Biologics | 147.15B |
| Sino Biopharmaceutical | 126.39B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.47B |
| Akeso | 104.46B |